Beam Therapeutics Inc. (BEAM)
NASDAQ·Healthcare·Biotechnology
$29.05
-1.22%
Mkt Cap $3.03B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (17 analysts)
$40.83
Range $26.00 – $74.00
Implied Upside
+40.6%
Consensus $40.83 vs current $29.05
NASDAQ·Healthcare·Biotechnology
$29.05
-1.22%
Mkt Cap $3.03B
Buy
4
Hold
0
Sell
0
Price Target (17 analysts)
$40.83
Range $26.00 – $74.00
+40.6%
Consensus $40.83 vs current $29.05